Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,963 public trials 2,020 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia

NCT00036257

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Cancer Centers of Florida Orlando, Florida, United States
  • Albany Regional Cancer Center Albany, New York, United States
  • Mary Crowley Medical Research Center (US Oncology) Dallas, Texas, United States
  • Tyler Cancer Center Tyler, Texas, United States
View Trial Details
Completed

A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)

NCT00073489

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Arizona Hematology & Oncology Associates Phoenix, Arizona, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • Florida Oncology Associates Jacksonville, Florida, United States
  • Ocala Oncology Center Ocala, Florida, United States
View all 15 locations
View Trial Details
Completed

A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies

NCT00051597

Conditions
DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +22 more
Locations
  • University of Alabama, Birmingham Birmingham, Alabama, United States
  • USC Norris Cancer Center Los Angeles, California, United States
  • University of Miami Miami, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

A Study of Subcutaneous and Intravenous VELCADE in Patients With Previously Treated Multiple Myeloma

NCT00722566

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • UZ Brussel Department Medical Oncology Laarbeeklaan 101 Brussels, Belgium
  • Hôtel DIEU, Service D'Hématologie Place Alexis RICORDEAU Nantes, France
  • Universitätsklinikum Münster Onkologische Ambulanz West Albert-Schweitzer-Str. 33 Münster, Germany
View Trial Details

Related conditions